Featured Research

from universities, journals, and other organizations

Study Opens Doors To Significant Changes In Medications For Schizophrenia

Date:
June 16, 2000
Source:
University Of Toronto
Summary:
Researchers at the University of Toronto and the Centre for Addiction and Mental Health have discovered that it is possible to have a medication that effectively treats schizophrenia while only lasting intermittently in the brain, thus reducing the prominent side effects traditionally associated with the antipsychotic drugs used to treat this severe illness.

Researchers have discovered that it is possible to have a medication that effectively treats schizophrenia while only lasting intermittently in the brain, thus reducing the prominent side effects traditionally associated with the antipsychotic drugs used to treat this severe illness.

The study, published in the June issue of the Archives of General Psychiatry, was conducted by researchers at the Centre for Addiction and Mental Health (CAMH) and the University of Toronto. The research opens the door to significant changes in how schizophrenia is treated.

"This is a significant finding because until now it was thought that in order for antipsychotic medications to be effective, they needed to be present continuously in the brain. This study fundamentally changes our understanding of how these drugs need to work," says Dr. Robert Zipursky, Clinical Director of the Schizophrenia and Continuing Care Program at the Centre for Addiction and Mental Health and Associate Professor of Psychiatry at the University of Toronto.

It is believed that antipsychotic drugs work by binding themselves to dopamine D2 receptors in the brain. Using positron emission tomography (PET), a brain imaging technique that makes it possible to measure the amount of medication in the brain, the CAMH / U of T research group previously demonstrated that antipsychotic medications need to occupy over 60% of the brain's D2 dopamine in order to be effective.

In this most recent study carried out by Dr. Zipursky, lead author Dr. Shitij Kapur and their research team, they found that when assessed 2-3 hours after the last dose of new antipsychotic medication, approximately 60% of the D2 receptors are occupied. However, 12 hours after the last dose, very little of the antipsychotic medication was bound to D2 receptors. These results suggest that antipsychotic medication can still be effective without having to remain at the target receptor site for a long period of time.

"Someone could receive the antipsychotic medication at night and be ready to function during the day without uncomfortable daytime side effects," says Zipursky. For years, psychiatrists have been battling to find medications for schizophrenia that do not have the prominent side effects frequently associated with these medications - including stiffness, restlessness and tremor - which often contribute to people's reluctance to stay on their medications. Zipursky says that the results of this study show that it is possible to design many more drugs in the future which need only act briefly on the brain, can be better tolerated and in turn contribute to improved functioning. This study was funded in part by Xeneca Pharmaceuticals.

The Centre for Addiction and Mental Health is Canada's largest centre in the area of mental health and addictions. A World Health Organization Centre of Excellence and a teaching hospital fully affiliated with the University of Toronto, the Centre was established in 1998 through the merger of the Addiction Research Foundation, the Clarke Institute of Psychiatry, the Donwood Institute and the Queen Street Mental Health Centre.

CONTACT:

Steven de Sousa
U of T Public Affairs
(416) 978-5949
steven.desousa@utoronto.ca
http://www.newsandevents.utoronto.ca

Chris Hendry
CAMH Public Affairs
(416) 979-4250
Chris_Hendry@camh.net
http://www.camh.net


Story Source:

The above story is based on materials provided by University Of Toronto. Note: Materials may be edited for content and length.


Cite This Page:

University Of Toronto. "Study Opens Doors To Significant Changes In Medications For Schizophrenia." ScienceDaily. ScienceDaily, 16 June 2000. <www.sciencedaily.com/releases/2000/06/000612161853.htm>.
University Of Toronto. (2000, June 16). Study Opens Doors To Significant Changes In Medications For Schizophrenia. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2000/06/000612161853.htm
University Of Toronto. "Study Opens Doors To Significant Changes In Medications For Schizophrenia." ScienceDaily. www.sciencedaily.com/releases/2000/06/000612161853.htm (accessed August 22, 2014).

Share This




More Mind & Brain News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Lost Brain Cells To Blame For Sleep Problems Among Seniors

Lost Brain Cells To Blame For Sleep Problems Among Seniors

Newsy (Aug. 21, 2014) According to a new study, elderly people might have trouble sleeping because of the loss of a certain group of neurons in the brain. Video provided by Newsy
Powered by NewsLook.com
Do More Wedding Guests Make A Happier Marriage?

Do More Wedding Guests Make A Happier Marriage?

Newsy (Aug. 20, 2014) A new study found couples who had at least 150 guests at their weddings were more likely to report being happy in their marriages. Video provided by Newsy
Powered by NewsLook.com
Charter Schools Alter Post-Katrina Landscape

Charter Schools Alter Post-Katrina Landscape

AP (Aug. 20, 2014) Nine years after Hurricane Katrina, charter schools are the new reality of public education in New Orleans. The state of Louisiana took over most of the city's public schools after the killer storm in 2005. (Aug. 20) Video provided by AP
Powered by NewsLook.com
Researcher Testing on-Field Concussion Scanners

Researcher Testing on-Field Concussion Scanners

AP (Aug. 19, 2014) Four Texas high school football programs are trying out an experimental system designed to diagnose concussions on the field. The technology is in response to growing concern over head trauma in America's most watched sport. (Aug. 19) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins